Editas Medicine
Price & Volume
Stats
See more52W Range | $0.91-$5.91 |
Market Cap | $241M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $35.8M |
Revenue Growth (YoY) | 310.4% |
Gross Profit (12 Mos) | -$161.4M |
Diluted EPS | -$3.04 |
News
See moreYahoo Finance • 12 days ago
Editas Surpasses Therapeutic Gene Editing Threshold in New Preclinical Data
Yahoo Finance • 28 days ago
Lilly-Verve deal sends gene editing stocks higher
Yahoo Finance • 28 days ago
Editas Medicine Is Great. Here's Why You Shouldn't Buy It.
About
CEO | Dr. Gilmore O'Neill M.D. |
CFO | Ms. Amy Parison |
Address | 11 Hurley Street, Cambridge, MA, United States, 02141 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 246 |
